Gensan S.R.L.

The research team at Gensan S.R.L. is dedicated to lowering the incidence of major adverse cardiovascular events by exploring innovative treatments for conditions such as elevated lipoprotein(a), hypertension, and atherosclerotic disease.

• Lipoprotein(a)–targeted therapies
• Advanced blood‑pressure management for high‑risk patients
• Prevention of heart attacks and ischemic strokes
• Integrated care for chronic kidney disease and cardiovascular health
• Risk reduction strategies for established cardiovascular disease

With a single experienced investigator overseeing seven trials, the site combines clinical expertise with a patient‑focused approach in Sibiu, Romania.

Studies conducted at the department aim to improve weight reduction outcomes and metabolic control in adults with obesity, overweight, and type 2 diabetes, testing novel agents that may also benefit kidney function.

• Weekly injectable therapies for sustained weight loss
• Oral agents that enhance glucose regulation
• Combined obesity‑kidney disease intervention trials
• Safety and efficacy assessments in overweight populations
• Exploration of metabolic benefits beyond weight reduction

The clinic’s integrated nutrition and metabolic program supports participants throughout the trial journey, reflecting its commitment to advancing metabolic health.